Revatio and Valcyte drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Revatio (sildenafil citrate) and Valcyte (valganciclovir hydrochloride). Common drug interactions include blood disorder among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Revatio and Valcyte. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Revatio?

Revatio has active ingredients of sildenafil citrate. It is often used in pulmonary hypertension. eHealthMe is studying from 44,849 Revatio users. Check the latest studies of Revatio.

What is Valcyte?

Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 6,409 Valcyte users. Check the latest studies of Valcyte.

On Jul, 15, 2026

15 people who take Revatio and Valcyte together, and have interactions are studied.

What are the common drug interactions of Revatio and Valcyte, by gender? *:

female:

Blood disorder
Cardiac failure
Death
Depression
Memory impairment
Uterine disorder

male:

Abdominal pain
Acinetobacter test positive
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Vomiting
Liver disorder (liver diseases)
Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Blood creatine increased
Blood lactic acid increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac arrest

What are the common drug interactions of Revatio and Valcyte, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Hypoacusis (loss of hearing)

40-49:

Abdominal pain
Acinetobacter test positive
Back pain
Escherichia test positive
Malaise (a feeling of general discomfort or uneasiness)
Nausea (feeling of having an urge to vomit)
Pulmonary oedema (fluid accumulation in the lungs)
Pyrexia (fever)
Tachycardia (a heart rate that exceeds the range of 100 beats/min)
Vomiting

50-59:

Multi-organ failure (multisystem organ failure)
Liver disorder (liver diseases)
Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Pericardial effusion (fluid around the heart)

60+:

Cardiac failure
Blood disorder
Uterine disorder
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac arrest
Death
Depression
Memory impairment
Pneumonia
Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

Cardiac Failure: 2 people, 13.33%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 13.33%
Portopulmonary Hypertension (coexistence of portal and pulmonary hypertension): 2 people, 13.33%
High Blood Pressure: 2 people, 13.33%
Sleep Disorder: 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%
Cardiac Failure Chronic: 1 person, 6.67%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 6.67%
Depression: 1 person, 6.67%
Diabetes: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Revatio and Valcyte?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously